BioArctic’s partner Eisai publishes statement relating to article on lecanemab in Scienceinsider
Stockholm, December 23, 2022 – BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today published a statement regarding an article on the safety of lecanemab ...